Allied Biotech Corporation (1780) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Allied Biotech Corporation (1780:TWSE), powered by AI.

Current Price
$29.80
Sector
Healthcare
What is the Allied Biotech Corporation stock price forecast?

Allied Biotech Corporation is currently trading at $29.80. View real-time AI analysis on Alpha Lenz.

What is Allied Biotech Corporation insider trading activity?

View the latest insider trading data for Allied Biotech Corporation on Alpha Lenz.

What is Allied Biotech Corporation's P/E ratio?

View Allied Biotech Corporation's valuation metrics on Alpha Lenz.

Allied Biotech Corporation

TWSE · 1780
NT$29.80+0.40(+1.36%)
Ask about Allied Biotech Corporation's future dividend policy...
Alpha Chat Insight

Allied Biotech Corporation's ROE is 10.7%. Explore profitability and growth together.

Ask for details

Company Overview

Allied Biotech Corporation is a biotechnology company specializing in the research, development, and production of carotenoid compounds. Founded in 2001 and headquartered in Taipei, the company is recognized as one of the world's leading manufacturers of carotenoids, ranking third globally and first in Asia for a comprehensive product range that includes beta-carotene, canthaxanthin, lycopene, lutein, and related derivatives. Its products serve critical functions as natural colorants and nutritional ingredients in the food, beverage, dietary supplement, and animal feed industries. Notably, Allied Biotech has secured multiple patents in both the United States and European Union for its proprietary production technologies, underscoring its commitment to innovation. In addition to carotenoids, the company manufactures precision chemical materials and other nutraceuticals, supporting sectors such as healthcare, veterinary medicine, and cosmetics. Allied Biotech's global distribution network extends across Asia, Europe, and the Americas, positioning it as a significant player in the international market for specialty food and wellbeing products. Its reputation is further supported by industry awards and recognition for technological advancement and revenue growth.

CEOQing Hui Lin
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$849.51MRevenue
0.00Shares Out
0Employees

Margins

36.33%Gross
28.55%EBITDA
14.17%Operating
19.32%Pre-Tax
15.24%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

5.83%Rev 3Yr
6.57%Rev 5Yr
5.76%Op Inc 3Yr
3.02%Op Inc 5Yr
-4.09%Net Inc 3Yr
10.25%Net Inc 5Yr

Returns

5.95%ROA
10.65%ROE
8.34%ROIC

Financial Health

NT$789.08MCash & Cash Equivalents
NT$68.11MNet Debt
69.43%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Allied Biotech Corporation (ticker: 1780) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

The current price is 29.8 with a P/E ratio of -x and P/B of -x.

ROE is 10.65% and operating margin is 14.17%. Annual revenue is $850M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Allied Biotech Corporation (1780) Stock Forecast 2026 $29.80 — Price, Financials & Analyst Targets | Alpha Lenz